I asked on Friday whether AIM-listed jam-tomorrow internet of things investment company Tern plc (TERN) had run into some problems with its proposed listing on the US OTCQB market. A trip to the SEC website asks more questions than it answers.
AIM-listed graphene play Haydale (HAYD) is up to its old tricks again with the release of an RNS Reach telling us that iCraft is using Haydale’s graphene product in a graphene-coated fabric. Yesterday we were told of the appointment of a new Nomad/Broker, today we get an RNS Reach. When’s the placing fellas?
I completely agree that Barclays (BARC) is not an exciting company and I consequently have probably written about it too many times on this website. Anyhow the good news is that this is likely to be the last time I will write about it. It is time for me to sell my Barclays shares.
AIM-listed Graphene play Haydale (HAYD) has appointed FinnCap as Nomad and Broker. So is it fundraising ahoy?
2021 was not a good year for bears. Markets were in a rip-roaring bull phase and in my view all common sense went out of the window, so even the most ridiculous speculative plays went up. But my strong view is that 2022 will be different: QE is being tapered away, interest rates are rising, inflation is soaring and government helicopter money is no longer there (at least for now). In 2021, bears had to hide behind the sofa and short positions could be attacked by an army of pitch-fork armed private investors. That is not the case now and I expect some hefty declines as a result.
Entirely predictably, AIM-listed John Zorbas vehicle URU Metals (URU) has slipped out its interim results on deadline day (never a good sign) in no-one-is-watching week, the few trading days between Christmas and New Year. As such it is a fabulous day to bury bad news……and there is, of course, plenty of bad news.
AIM-listed Mediazest (MDZ) offered up a trading statement yesterday and I wonder why. There were positive noises, of course, but this was a trading statement apparently covering the second half of the year ending 30 September 2021! Last year it offered up its year-end statement, including the second lockdown, on November 12th 2020. Why has it taken Mediazest an extra month in an environment somewhat less affected by Covid this year?
AIM-listed jam-tomorrow internet of things investment company Tern plc (TERN) has announced a fundraise at investee INVMA resulting is an upwards revaluation of its investment. Two other investors have stepped up to the plate in the form of Foresight and Mercia, stumping up £1.925 million between them (presumably of other people’s money) to add to a further investment from Tern of just £0.2 million. Good news for INVMA, as it now has cash – and good news for Tern as at least one hungry mouth to feed has been satiated for the time being.
I have been watching Companies House with interest recently, regarding AIM-listed jam-tomorrow internet of things investment company Tern plc (TERN) and its principal investee Device Authority (DA). Following news of the bailout investment of yet more cash into DA, I have a few questions. Call be a pedant, but……
Aquis-listed Rutherford Health (RUTH) – formerly Proton Partners – announced this morning that it has secured bridge financing from shareholders including Neil Woodford’s former stamping ground of Schroder UK Public Private Trust (SUPP) – formerly Woodford Patient Capital – and LF Equity Income Fund – the unsaleable rump left over from the Woodford Equity Income fund – to raise up to £10 million in the form of various loans costing 15% per annum. The old saying that if you owe the bank a quid you’ve got a problem, but if you owe the bank a million quid then it is the bank which has the problem is writ large here.
AIM-listed graphene products company Haydale (HAYD) has released its full year results to June 30 2021. Amongst the highlights we are told of a “robust trading performance” and the “Summary of Results” shows that cash outflow from operations was down by 52% whilst cash at year end was up by 100% at £1.64 million. So all is well, right? Think again…..
Well surprise, surprise! AIM-listed Advanced Oncotherapy (AVO) has announced that the first fully operational LIGHT system has been delayed from the end of this year to the end of Q1 next year. I noted HERE that the delay announced this morning was pretty well baked in. Given that we have moved from “could slip into Q1 2022” to “around the end of Q1 2022” in the space of less than two and a half months, it seems to me that further slippage is highly likely. Indeed, despite this morning’s announcement, one wonders whether any progress has been made at all since the announcement of diabolical interims at the end of September. So there will be at least another quarter sans revenue……what about the cash?
Having posted my five slam-dunk sells for 2021 at the start of the year and watched in amazement as the market bid up complete rubbish, it is time to take stock as the year draws to a close. My sells were Tern (TERN), Catenae Innovation (CTEA), URU Metals (URU) and Yu Group (YU.) – all roll-overs from 2020 – and Trafalgar Property (TRAF), which came in as a replacement for the defunct ShareProphets AIM-China Filthy Forty play Walcom (WALG).
AIM-listed jam-tomorrow IoT Investment company Tern (TERN) has announced yet another roll-over with regard to the loan notes from principal investee Device Authority. This is a repeating pattern: every six months the maturity is pushed back another six months and the latest is that they have been pushed back to the end of March 2022. One might gently wonder if Device Authority will ever be able to pay them off or whether the conversion terms will be invoked due to lack of cash.
Aquis lobster-potted Rutherford Health (RUTH) – formerly Neil Woodford favourite Proton Partners – has announced a deal to open new health clinics in partnership with BUPA. Great, whizzo……but there is just one tiny little thing wrong here!
Noting I would keep my watchful eye on Aquis lobster-potted Truspine (TSP) in the wake of a Christmas 2020 update that its FDA-approval paperwork was three months behind more-or-less on deadline day, I see that the company has announced that it has applied for its Cervi-LOK spinal product to be designated as a “Breakthough Device Technology”. Whatever……here we are in November and the FDA 510k application for this device, originally due last Christmas, has still not been filed. But it gets worse……
I cannot help but notice that shares in AIM-listed John Zorbas vehicle URU Metals (URU) have crashed by 19% thus far today, on no news. Having called it a sell at 405p in August, a sell at 320p in September and a sell at 270p earlier this month, the stock is now down to 190p. Of course, it is still a sell but perhaps it is time for an early Ouzo as the shares have now more than halved.
AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) has released a portfolio update this morning. Naturally the BBMs are pleased as punch but I fear that, once again, the company has borrowed the Adam Reynolds (who, for the avoidance of doubt, has nothing to do with Tern) keyboard, for there are no meaningful numbers to be found – and the few included are pitiful.
Oh dear oh dear. AIM-listed jam-tomorrow IoT investment company Tern (TERN) principal investee Device Authority has just posted amended FY20 accounts at Companies House. Given that the original accounts were signed off back in January but not posted until 21 September 2021, that looks like carelessness – as do the missing Notes to the Accounts. And then there is an increased £4.6 million liability, apparently owed to nobody!
When I commented on AIM-listed URU Metals (URU) at the end of August, following the “disposal” of its Zebediela nickel asset to TSX-V listed cash shell (with no cash) Blue Rhino, now Zeb Nickel (TSX-V:ZBNI) the shares were 405p and I said sell as it was an accident waiting to happen. By mid-September they were down to 320p and I still said sell. Now, following after-hours full year results to March, slipped out at no-one-is-watching o’clock on deadline day (never a good sign) – and showing it had net current assets of MINUS $1.5 million – the shares are down again, to 270p – and in my view they are still monstrously overvalued and a sell.
AIM-listed URU Metals (URU) – the firm which prefers to mine its own shareholders rather than anything in the ground, according to Cynical Bear – slipped out its full year results to March last night at 5.35pm on deadline day. Truly, this is no-one-is-watching o’clock, but ShareProphets was watching and the numbers are – again – horrendous.
AIM-listed Rurelec (RUR) has been an untold disaster on AIM. Having ditched the Peter Earl regime, the directors who somehow managed to keep this crock afloat have now left and the outlook is truly grim.
Oh dear, oh dear, oh dear. AIM-listed Advanced Oncotherapy has announced its interims to June: the numbers are predictably dreadful but the killer is surely the indication of a delay to the completion of the company’s first proton therapy LIGHT system.
AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) has a history of not keeping its own investors abreast of what is going on going almost all the way back to when Tern was formed out of the wreckage that was Silvermere Energy back in 2013. An eight year history of deceiving investors?
AIM-listed Igas Energy (IGAS) has reported its interim numbers to June 30 2021 this morning and despite tables covering EBITDA (bullshit earnings), adjusted EBITDA (double bullshit earnings), underlying cash operating costs (more bullshit earnings) and operating cashflow numbers (yet more BS) the bottom line shows that Igas lost another whopping amount and the balance sheet shows that it was technically insolvent. If this isn’t another trainwreck in the making then I’m a banana (to borrow a phrase from Ian Hislop).
Aquis lobster-pot listed TruSpine (TSP) has announced a placing raising just £650,000 – of which only £500,000 of actual cash was raised (the balance being fee shares, one presumes to the fine Broker involved to cover coke and hookers costs). Quite why anyone would pay 10p for shares which are trading at just 8.75p (up 0.65p) even after the announcement) is beyond me! But the highlight was the update over FDA submission for its Cervi-LOK product.
In my last piece on AIM-listed Haydale (HAYD) at the beginning of this month I discussed a ramparoonie RNS revealing an undeclared related party and a tin-pot organisation casting a very different light on matters as presented by the company. What was the point? Of course – it was a pre-placing ramp and this morning it was time for Ouzo on cornflakes as Haydale revealed a fundraise at just 6p per share. That, against a peak last week of 7.55p.
Last night at 5.20pm AIM-listed Rurelec slipped out its full year results to December 31 2020. Given that its previous team of directors slipped out of the door since period end, the evening of Boris Johnson’s cabinet reshuffle looks like a good time to bury bad news.
On 3 September AIM-listed Angelsey Mining (AYM) released predictably horrid full year results to March 2021. This morning it has graced the market with an RNS entitled Financial Results and way Forward. Confused? I was……until I realised this morning’s missive didn’t include the full results!
AIM-listed Haydale (HAYD) has announced a Memorandum of Understanding with a company called Viritech Limited via and RNS Reach this morning. Of course, and RNS Reach is not a full RNS and should be treated more as marketing material, certainly with no implied financial impact. A trip to Companies House shows us why……
Sub-Standard-Listed Cloudbreak Discovery (CDL), which rushed its way onto the Standard List only in June as Imperial X (IMPP) before it had even managed to change its name amid a forest of Red Flags, has announced an industrial trough-load of options for directors, PMDRs and other staff. Its nice to be valued, but what about the shareholders?
The last time I commented on AIM-listed Mediazest (MDZ) in May, having previously noted a balance sheet calamity, I called for a statement from the company regarding its chairman, Mr Lance O’Neill and his relationship with Claremont Capital Assets Limited (CCAL) as a related party.Needless to say, we’ve heard nothing from the company about that. This morning, however, we have a trading statement. Given that its next reporting period end is September 30th, one has to wonder why….until you consider its car-crash of a balance sheet. I suggest this is all leading up to a bucket shop special.
It has been a busy few weeks for AIM-listed John Zorbas vehicle URU Metals (URU). The “sale” of its Zebediela nickel project in South Africa to Toronto Venture Exchange listed (lack-of) cash shell Blue Rhino (RHNO), now renamed ZEB Nickel (ZBNI) has completed, with Zeb having raised some cash along the way. But it seems that the Toronto market is less than impressed.
AIM-listed jam-tomorrow investment company Tern plc (TERN) has announced a portfolio update…..and that it has piled another £630,000 into its portfolio. But that seems to be about the only number offered.
AIM-listed protons beams for cancer outfit Advanced Oncotherapy (AVO) announced a proposed £40 million fundraise yesterday – the largest to date – at 40p per share, a 17% premium to its average closing price over the past month, and a 13% premium to the previous close. I have to hand it to the company, that’s a great effort. But does it make the shares a buy?
AIM-listed Catenae Innovation (CTEA), which is almost revenue-free and surely heading for a Christmas cash-crunch, has announced a “Data Visualisation Oder” from SaxaVord UK Spaceport at a satellite ground station in the Shetland Islands. Good news…..or not, for we are told that revenues created from the order are not significant. So another revenue-free project, then!
I have said before that some people are just in the wrong place at the wrong time. Well, actually, just one. This is with regard to sub-Standard-Listed BSF Enterprise (BSFA) and its new NED as announced this morning.
AIM-listed Catenae Innovation (CTEA) has announced yet another RNS Reach – this time over a deal with Promake Ltd – but it is still, on the basis of its interims to March, almost revenue free and heading for a cash-crunch by Christmas. But never mind that, it’s got a deal with Promake…..which offers yet more Red Flags!
AIM-listed John Zorbas outfit URU Metals (URU) had a good day in the market yesterday as its shares shot up by 8% to 405p on news of developments regarding its “disposal” of the Zebediela nickel project in South Africa to Toronto Venture Exchange listed Blue Rhino (RHNO). Except as far as I can see it is not really a disposal as one might normally understand the word.
I have covered the downs and further downs of AIM-listed Rurelec (RUR) in some detail since the demise of former management led by Peter Earl, and marvelled at the fact that the company – despite everything thrown at it – is still here at all. But this morning’s announcement of a new “Independent” NED makes the stock totally uninvestable. So who is the mystery NED?
AIM-listed alternative energy supplier Yu Group (YU.) has updated the market this morning with a trading statement for the half-year to June. We are told of strong growth in bookings ad revenue with confidence in delivering profitable growth, but whilst cash balances are broadly flat (ie a little down) over the period there is again no discussion of net current assets. So is it just more of the same?
The morning, AIM-listed Catenae Innovation (CTEA) trumpeted a new pilot programme with a charity. Bully for it, but to me this morning’s RNS is extremely bad news and this is why.
What is AIM-listed jam-tomorrow investment company Tern plc (TERN) really worth? At the close of play on Friday the shares were down 11% at 24.5p, valuing the company at £81 million. But its last-stated NAV per share was just 7.3p, which would value the company at a far more modest £24 million. The problem is that Tern’s stated NAV per share has been shown to be (if you’ll pardon the pun) Wyldly optimistic. I believe the last stated NAV should be more like £17.4 million – and that is being generous.
So the truth is out. AIM-listed jam-tomorrow investment company Tern plc (TERN) teased the market with plans to list investee Wyld Networks in Stockholm on the Swedish Nasdaq First North market. The BBMs went (ahem..) wyld with excitement, marking Tern’s shares up as high as 29p against a last-stated NAV per share of just 7.3p as the IPO approached. Tern was going to the moon…….until today.
AIM-listed Catenae Innovation (CTEA) has announced its delayed FY20 results and Interims to March 2021. You can’t say we didn’t warn you: in short, the numbers are calamitous and the shares are an outstanding sell. It is Ouzo on Cornflakes time!
As we all know, intra-day trading statements are usually bad news and today’s update from AIM-listed and holed below the waterline by former management Rurelec (RUR) is no exception.
My five AIM anti-tips for the year continue to defy gravity. I suggested in my last column on this that perhaps it should perhaps be renamed the Market Madness Index. Anyway, for what it is worth, here is how things stand.
Yet more red faces for Andrew Monk and his team at VSA Capital which launched this abomination on the stockmarket and still acts as its adviser. But I guess that coke and hookers don’t pay for themselves and a man’s got to do what a man’s got to do. What a total shambles! Sub-Standard-listed AIQ (AIQ) has announced the result of its strategic review this morning – this as a result of the disastrous reverse takeover of Alchemist Codes to add to the original and equally shambolic IPO on the sub-standard list back in 2018 which saw the stock suspended for most of its first six months on the market.
Fully listed Esken Limited (ESKN), formerly Neil Woodford favourite Stobart Group Ltd (STOB), has announced that – as I suggested back on 31st May – the sale of Stobart Air and Carlisle Lake District Airport to Ettyl Limited has collapsed. Worse still, support for Stobart Air has been terminated, Stobart Air has terminated its franchise agreement with Aer Lingus, will cease trading and liquidators are to be appointed. The pain for Esken does not end there, but later on it confirmed talks to potentially sell 30% of London Southend airport. But that’s not the whole story……
On Friday morning at 7am fully-listed former Neil Woodford favourite Esken (ESKN) – formerly known as Stobart Group Ltd (STOB) – announced that its proposed sale of Stobart Air to Ettyl Limited was being delayed by change of control consents taking longer than planned. Given that the sale was due to complete by early May 2021 announcing this on the last trading day of May seems a bit ripe. But worse was to follow.
AIM-listed Yu Group (YU.) had its AGM this week. All the resolutions were passed, as one might expect, but the company talked of being profitable in the second half of last year and continued momentum from FY20 as 2021 got off to a good start. But profit – as we all know – is a matter of opinion; cash – where Yu’s dangers lie – is a matter of fact.
AIM-listed and technically insolvent as at Christmas Inspirit Energy Holdings (INSP) has announced yet another discounted placing this morning, raising £500,000 at a price of 0.05p per share, to keep the lights on. That, against a closing price yesterday of 0.06p yesterday means the discount was 16.7%, although for some curious reason the stock has been sliding since May 17 when it was 0.07p. But naturally enough, since this is AIM there is no chance of insider dealing.
Last night, at 6.02pm – no-one-is-watching o’clock – AIM-listed URU Metals (URU) announced it has increased the death spiral facility with an outfit called Boothbay Absolute Return Strategies from $250,000 to $500,000 – and the bargain giveaway conversion terms which were originally due to expire within 90 days of the original loan have again been extended so that Boothbay can convert at just 85p……with the stock trading at 325p!
Things were looking up at AIM-listed Rurelec (RUR) when I last commented here, but yesterday morning came bad news from Argentina. In honour of which our esteemed site editor has added a video to this article which will bring tears to your eyes. But first Rurelec and its news…
AIM-listed Catenae Innovation (CTEA) has waxed lyrical this morning about the acquisition of Hyperneph Software Limited. The acquisition – a 51% partial stake in the outfit – is set to cost Catenae’s grateful shareholders £270,000 in cash and £50,000 in Catenae confetti to be issued at the end of February next year at a 10-day VWAP. The transaction is classed as a Related Party Transaction as one former director of Catenae is on the board of Hyperneph, alongside a former employee and current adviser to Catenae.
It’s Spring cleaning time. And with the markets closed, it’s an ideal time to condemn stuff you don’t want, as charity shops faced with a 17% rise in donations are finding out. And it’s also time to divest yourself of shares which are dragging down your portfolio. It’s been shown time and time again that holding onto duds limit your performance more than finding winners. Nothing is guaranteed in the chaos that is Shareland. But there are a few guidance notes, if not rules, for keeping your portfolio in a tidy and profitable state. Here they are.
Tom Winnifrith has already exposed the cancer threat, discussed HERE in a 2018 scientific study, posed by wearing graphene enhanced face masks with regard to AIM-listed Versarien (VRS). But it seems that Versarien is not the only company in the firing line, for AIM-listed Haydale (HAYD) is also on the hook.
Here is another piece of fake news from Alliance News: “Losses widen at BSF Enterprise but cash position strengthens”. This followed the release by sub-Standard Listed cash-shell BSF Enterprise (BSFA) of Interims to March 2020 – just over three weeks AFTER it released full year numbers to September 2020 (which were released a day late on April 1st despite having been filed to Companies House on 4th March. What sort of shambles is this?
Schroder UK Public Private Trust (SUPP) – formerly Neil Woodford’s Patient Capital Trust (WPCT) – slipped out a new but unaudited net asset value statement yesterday at 3.32pm and it was shocking: it wiped another 20% off the previously stated NAV to bring the official figure down to just 35.01p per share. That, against the fantasy 89.07p when the flagship Woodford fund, Woodford Equity Income, was gated on 3 June 2019.
It is a while since I took a look at AIM-listed Igas Energy (IGAS) – the last big round of coverage followed Andrew Austin and his dodgy deal with Equities First, and the subsequent refinancing which we correctly called as the oil price plummeted. Today, the company revealed its accounts for FY20 and there was a striking similarity……
Oh dear, oh dear – I would have thought that the board of AIM-listed John Gunn enterprise (or lack of it) Inspirit Energy Holdings (INSP) would have learnt by its previous errors. But alas, no. For five of the last six years, Inspirit has missed the deadline for filing its Confirmation Statement or Annual Return……and guess what?!
Cash-shell BSF Enterprise (BSFA) of the Sub-Standard List (surely two Red Flags already!) published its FY numbers to 30 September 2020 this morning – April 1st. Those with a sharp eye might notice they are a day late – which is a bit of a mystery given that they were signed off by the Auditor (PKF Littlejohn) and Geoffrey Baker on behalf of the board a month ago on March 1st, filed at Companies House on 4th March and released by Companies House on March 12th! So much for shareholders finding out what is going on via the RNS system first!
There may be no limit to the stupidity of the lunatic fans of AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) but the market’s early reaction to this morning’s FY20 results – a drop of 18% – suggests that you can’t fool all of the market all of the time. In short, the numbers are a calamity.
AIM-listed Yu Group (YU.) released its Full Year numbers for 2020 this morning which show continued cashburn, a horrible lack of balance sheet support and negative net current assets. As I had suspected, the trumpeted cashpile announced in the FY Trading Update was a mirage, with payables up and receivables down. The shares may have been on a tear recently, but the company is heading for a brick wall.
It was announced this morning that AIM-listed Catenae Innovation (CTEA) is to delay releasing its accounts to 30 September 2020 with the blessing of AIM Regulation, which has given the company until the end of June on the grounds of the Covid pandemic. I will come to this later, but we were also treated to a trading update……which was indeed a treat, if you are a bear.
Technically insolvent AIM POS St James House (SJH) made a song and dance yesterday of its latest bailout rescue finance package – which neither bails it out or rescues it – with Tintra Acquisitions Limited. There is a £250,000 loan convertible into a death spiral at 10p per share (take note shareholders, with the price currently 45p a pop!) but tied to that are two option deals which apparently bring in between them a fraction below £180,000. So how much of that will find its way onto St James’ balance sheet?
The good Professor Conroy and his team at AIM-listed Conroy Gold and Natural Resources (CGNR) must be feeling very pleased with themselves this morning, as the company announced a decent-sized fundraise to bring in £1.87 million in cash (before expenses) and a debt-for-equity swap regarding outstanding director fees and other debts to wipe out £379,000 of monies due. So does this finally cure Conroy’s long-running illness of technical insolvency, as highlighted by the Auditor in November’s FY accounts to May?
Neil Woodford’s shambolic Patient Capital Trust (WPCT) – now Schroder UK Public Private Trust (SUPP) after Woodford’s disgrace – has announced the completion of an asset sale to bring in £52.9 million. In theory this is good news, but since the original sale was announced as being at a 19% discount and the vast majority of the cash is being used to part-pay the bank there really isn’t much to celebrate for shareholders.
When I last looked at fully-listed Hammerson (HMSO) last September, it had just raised money to, in effect, start again. But since then Bonkers Boris has locked the country up for a second and third time and as such there was simply no attraction for me to this property (lack of) income play.
I commented back in January on AIM-listed URU Metals (URU) and its proposed sale of the Zebediela project in South Africa to Canadian-listed cash (-less) shell Blue Rhino Capital. Suffice to say I wasn’t impressed. Yesterday the company called its AGM and on the agenda is this “disposal”.
AIM-listed Mediazest (MDZ) has finally released results for its extended 18-month period to September 2020, and the numbers are a calamity as the Red Ink dribbles from every page. Of course, ShareProphets readers were forewarned, so I hope you have missed out on today’s share price drop of 10.5% thus far.
AIM-listed jam-tomorrow investment company Tern plc (TERN) has offered yet another portfolio update – this time entitled Portfolio News – the fourth such effort so far this year. If at first you don’t succeed (in ramping your shares), try, try and try again! But with nothing of substance to report (Moi? A cynic?) today’s ramparoonie is merely and RNS Reach.
AIM-listed Anglo Asian Mining (AAZ) has walked on its proposal with fellow AIM-listed Conroy Gold and Natural Resources (CGNR) to form a joint venture with Conroy’s gold assets in Ireland. Not such a disaster for Anglo Asian, but there is a question over who pushed who and when. Meanwhile, it seems that Anglo has been replaced by Turkish outfit Demir Export AS.
The long-running saga of AIM-listed Mediazest (MDZ) and its full results continued this morning, with first a promise to release full numbers for the year to September 2021 eventually replaced with a promise to offer up numbers to September 2020 next week. Apart from the comedic cock-up involving Mediazest’s crystal ball, how sure can we be that the promised numbers will indeed be served up in the coming week? Not very, I fancy!
AIM-listed Haydale Graphene (HAYD) has offered up its interims to December 2020 today and whilst the company flags increased sales of functionalised inks graphene and points to falling admin costs and operating losses, these are on an adjusted basis. The unadjusted truth is that sales of £1.277 million were down from £1.347 million the previous year and the company lost £2 million in total comprehensive loss (although this is marked as being for the year – not that there was an cut’n’paste laziness!)
AIM-listed Catenae Innovation (CTEA) offered up more than its fair share of RNS Reaches last year and this morning we have another. Remember, and RNS Reach is classified essentially as marketing material, yet the shares are up by a whopping 45% at 2.75p, having climbed as high as 3.15p!
On February 11th AIM-listed Mediazest (MDZ) announced that it expects its results for the 18-month period to 30 September 2020 to be announced by the end of the month. Next week is the end of the month – the question is whether its expectations are to be believed, or whether they are in the same mould as Tom Winnifrith’s expectations with regard to Britain’s favourite chanteuse.
AIM-listed Mediazest (MDZ) caught my eye this morning: it is currently top of ADVFN’s gainers leaderboard today with a rise of a very impressive 140%, with a share price of just 0.12p – having been as high as 0.175p. There was news of new business wins due to bring in £350,000 of revenues but as we know, revenues are one thing and cash is quite another. But apart from that, it looks like a forest of Red Flags is upon it: have the Bulletin Board Morons completely lost the plot? TW Note did they ever have it?
I noted the old adage last week of if you don’t succeed, try and try again. Last week AIM-listed jam-tomorrow investment company Tern plc (TERN) offered up its second portfolio update of the year. This morning we were treated to a third: so is it jam-today, then? Or doth the lady protest too much?
If at first you don’t succeed, try and try again. An old rule which it seems that AIM-listed jam-tomorrow investment company Tern plc (TERN) is adhering to. Last month it offered up a Portfolio Update which seemed to me to be meaningless drivel. Now, less than a month later, we have another.
There was bad news this morning from AIM-listed cancer-buster Scancell (SCLP): Cancer Research UK has pulled out of a funding deal to put Scancell’s second SCIB product through Phase I/II trials.
I wondered about the complete non-mention of those clever face masks that AIM-listed Haydale Graphene (HAYD) is supposed to be producing shed-loads of graphene for with regard to the trading statement last week. The more I think about it, the more surprising it is.
AIM-listed Haydale Graphene (HAYD) offered up a statement on Thursday telling of a sales representative agreement and a trading update. The former offered up visions of Tom Winnifrith’s (lack of) wooing Britain’s favourite chanteuse but the latter seems to me have been more a case of the dog that didn’t bark. What was the first elephant in the room?
AIM-listed Catenae Innovation (CTEA) – fresh from its fundraise announced Wednesday which added £1 million to its coffers at 2p per share – has announced a new pilot agreement for its Covid-bandwagon testing platform with an unnamed Fortune 500 American professional services and construction company. But if the BBMs think this is exciting, we are again warned that the deal is not expected to generate substantial revenues. Or, indeed, any revenues at all.
AIM-listed jam-tomorrow investment company Tern plc (TERN) has announced a new injection of capital into investee Wyld Networks offered up by Tern and a third party investor which previously made loans of £400,000 to Wyld. In addition, the two investors have converted loans into equity which cleans up the balance sheet but the big point Tern trumpets is that its previous investment which carried a valuation of £1.2 million is now worth £4.1 million. So it looks a great job for Tern – but I refer readers back to Cynical Bear’s piece on fellow Tern investee Cryptosoft, now called Device Authority, on the merger between Cryptosoft and Device Authority Inc.
Schroder UK Public Private Trust (SUPP) – the former Woodford Patient Capital Trust has today announced the sale of seven assets for a total of £51.9 million. Well done, you might say – until you read that this represents as discount of some 19% to the forex adjusted (as at 25 January) valuations as at 30 September 2020. Not so hot, all of a sudden.
AIM-listed technically insolvent POS Trafalgar Property (TRAF) today announced a director share purchase: CEO Paul Treadaway has bought a million golden tickets. The stock is up on the news, but I fear that this is just a textbook spoof.
Sub-Standard-listed AIQ has had a chequered history since it floated on the London Stock Exchange courtesy of Andrew Monk and VSA Capital. The founding executive directors’ full details had not been correctly disclosed, there was the mother of all shambles as IPO share certificates failed to arrive in a timely manner and at the same time a buying frenzy – perhaps by people who thought there was a relationship to Mama Captain (denied), the stock spent most of its first four months as a listed entity suspended and even a placing to address the IPO shambles was messed up. Meanwhile, the stock was trading (when not suspended) at a ridiculous premium to cash, with no business.
The good news is that we did not have to wait until after-hours on New Year’s Eve for the latest set of Interim Results to September from AIM-listed John Zorbas POS URU Metals (URU). But the numbers are, as predicted, truly awful – it is Red Flags ahoy from this technically insolvent joke company.
At 1.25pm AIM-listed POS Inspirit Energy (INSP) issued a statement relating to fellow AIM-listed Octagonal, where its CEO and Chairman John Gunn, and Finance Director Nilesh Jagatia also reside in the same roles, whose subsidiary, Global Investment Strategy is Inspirit’s sole broker – the very same subsidiary which has been charged by the SEC – alongside John Gunn, for aiding and abetting – with violating US broker-dealer registration provisions of the Securities Exchange Act 1934. Given that Jagatia and Gunn make up two thirds of the board of Inspirit, there clearly is a problem here!
As we approach the end of 2020, it is time to take a look back at my Tips of the Year in the ShareProphets Christmas 2019 Tipfest. AIM-listed investment company Tern plc (TERN) was my first tip – as a sell, at 9.25p. So how have I done?
AIM-listed jam-tomorrow (or never) Internet of Things investment company Tern plc (TERN) has seen its shares continue to crater – the shares are now, at 6.7p, well below the last placing price of 7.5p. Meanwhile investee FVRVS Limited (Fundamental VR) has filed its 2019 accounts……and…..oh dear!
Yesterday I took apart the ramptastic announcement from AIM-listed Catenae Innovation (CTEA) regarding its joint venture with BHA Medical, and showed that the JV vehicle was worth just 10p. But the nonsense does not stop there.
AIM-listed Covid-ramp Catenae Innovation (CTEA) has announced that its joint venture with BHA Medical, now renamed Synovate Global Ltd (today the world, tomorrow the universe!), has got two orders for its package involving BHAs Covid test kits and Catenae’s data management platform. Whoopie-do, let’s all pile in –this is going to take over the world. Or not…….there is a catch!
I haven’t written about AIM-listed Vast Resources (VAST) since January, when I said sell at 0.335p. Well, the stock is now 0.1375p so I guess it is time for an Ouzo – but a director share purchase announcement makes me think it is still a sell.
Corero Network Security (CNS) has made an “Order Intake” update, emphasising “positive progression… reflected in the associated order intake of more than $3 million in the first two months of the final quarter of 2020” – and the shares have currently responded to 9.5p, more than 15% higher. Does this look justified?…
Shares in AIM-listed jam-tomorrow (if ever) investment company have again been dribbling south, closing yesterday at 6.95p. With a load of freshly raised cash and a new investment to boast, surely things are going well for Tern……but alas the market seems to be taking a different view. Of course, Tern has a habit of keeping quiet when there might be something to clear up – such as the recent speculation (unfounded, as it happens) on the BBs about Wyld. And that brings me to its 50%-owned investee InVMA.
Like its AIM-listed little sibling Karelian Diamonds (KDR), fellow AIM-listed Conroy Gold and Natural Resources (CGNR) has had six months to release its FY numbers and waited until no-one-is-watching o’clock on deadline day to admit the grizzly truth. But luckily once again ShareProphets was indeed watching.
AIM-listed Haydale Graphene (HAYD) has announced the great achievement of its Functionalised Graphene Antibacterial Masks project going into production with partner IRPC Public Company. Put up the bunting, get the champagne ordered……or perhaps not, for surely it has missed the boat.
Well blow me down: AIM-listed John Zorbas POS URU Metals (URU) has rattled the tin and got someone to fork up at 230p per share. Apparently that is around a 10% discount, but given the paltry return for the company it says nothing that is good about the company. A few coins for the electricity meter and, er…..that’s about it.
AIM-listed jam-tomorrow investment company Tern plc (TERN) has announced a contract for investee FundamentalVR (FVRVS) but it seems the market in unimpressed and shares in Tern have again fallen below the recent fundraising price.
Previously writing on castings and engineering company Chamberlin (CMH), in February with the shares at 24p I noted financials & Premier Miton concerns. Today a “Trading Update”… and the shares at 9.5p, a further more than 15% lower on the back of it…
Shares in John Zorbas AIM outfit URU Metals (URU) are up today on the news of an advisory board appointment. The company announced the hiring of Mr Justin Cocharne to URU’s advisory board and the shares have motored by 6.4% to 250p but I just have one question: how will URU pay for his services, given that the company is quite clearly technically insolvent?
On Tuesday I wondered whether AIM-listed Tern (TERN) was already conducting a discounted placing as its shares were again falling even in the face of yet more ramptastic news. Now we know that the company was again raising money on the back of fake news in the market which it has failed to comment on as the BBMs were frothing about tiny investee Wyld.
I wonder if AIM-listed jam-tomorrow investment company Tern plc (TERN) is already working on a placing, for this morning’s ramptastic Portfolio Update offered as the market celebrates the vaccine news from Pfizer saw the shares come off 7% to 9.5p before a partial recovery. Are placees already selling, or has the market seen through the promise of yet more jam tomorrow? But one thing is for certain: Tern needs more cash pronto.
AIM-listed technically insolvent John Zorbas POS URU Metals (URU) announced yesterday that it has for the second time extended the initial 90-day initial notice period on its convertible death-spiral loan by a further 90 days. With the shares at 260p, the initial deal to convert the loan is massively more attractive for the loan shark than the 35% discount that would otherwise apply – so why is URU doing this?
AIM-listed graphene outfit Haydale Graphene Industries (HAYD) was “pleased to announce” its interims to June this morning – I’m not sure why, for a £14 million market capitalisation company to offer up a pre-tax loss of £4.4 million in just six months is surely nothing to be pleased about.
There is that old saying that when good management (although the jury is out on that) meets a bad company it is the reputation of the latter which survives. And that brings me to AIM-listed uber-dog St James’ House (SJH) – formerly Lib Dem grandee Lord Razzall disaster Boxhill Technology (BOX). We’ve had funding not arrive, vacuous trading statements and now this morning the company tells us it cannot get its accounts out on time. So why has AIM Regulation not suspended the shares forthwith?
AIM-listed Advanced Oncotherapy (AVO) has announced a fundraise at 30p to raise £7.7 million (before expenses) – as predicted HERE by yours truly. Time for another glass of Ouzo, methinks.
Evil Knievil always used to say that the best time to kick a man is when he is down. And so I return to AIM-listed jam-tomorrow, next year, never investment company Tern plc (TERN) where I see that the shares are once again down.
I have been warning about AIM-listed jam-tomorrow, next year, never investment company Tern (TERN) for years, but this year made it my sell of the year on the grounds that I thought this would be the year when investors finally gave up on the jam-tomorrow promises. Having hit a high point this year of 15.75p, this morning the stock is down to just 5.5p. But its (claimed) NAV per share is 7p – surely that makes Tern a buy? Er…..
Gary Newman stuck the knife in to AIM-listed Adamas (ADAM) – of the ShareProphets AIM-China Filthy Forty, no less – at the beginning of September when it announced a share buy-back at a higher price than a placing and open offer first announced in July, but which only completed today – and only partially. If that is not bonkers enough, it seems that a large chunk of the placing cash is yet to arrive. We were told yesterday that:
At least we weren’t told anybody was pleased to announce these results on Wednesday morning, but the numbers offered up by AIM-listed Trafalgar Property (TRAF) were once again horrific. And something simply does not ring true.
AIM-listed Yu Group (YU.) announced its Interims to June this morning – deadline day, never a good sign – and the balance sheet shows it is in a mess.
AIM-listed jam-tomorrow investment company Tern (TERN) has released its interim results this morning and they show no progress at all. Indeed, there are a few little Red Flags to be spotted.
Yesterday another adviser to AIM-listed jam tomorrow investment company Tern (TERN) has departed the building. We have already this year learnt that Tern’s Auditor slipped out of the back door under cover of night, and it is not so long ago that Allenby took on the role of Nomad, leaving one wondering if the former incumbents jumped or were pushed, shortly after Redleaf had vacated the PR role. Now Broker Whitman Howard has jumped ship. Should shareholders be concerned?
As the saying goes, these are unprecedented times. But I’m not talking so much about Covid-19 as the manic state of the markets, with special reference to the AIM Casino. And that brings me to my list of five slam-dunk sells for 2020.
I have warned and warned and warned that AIM-listed Haydale (HAYD) needed more money and having jumped on the Covid-Bandwagon at the beginning of July and seen its shares slide from 8.45p on 20th August to last night’s close at just 5.1p, this morning the company announced a bookbuild at just 3.5p to raise £3 million. The only question is whether it should be Ouzo on my Cornflakes or my Rice Krispies.
AIM-listed but BVI-registered URU Metals (URU), which as Cynical Bear put it, seems more interested in drilling shareholders’ pockets than the ground, has announced a ramptastic pre-placing RNS this morning. Of course, we all knew it was coming as by my maths this John Zorbas POS is still technically insolvent and the clue is hidden in today’s announcement.
AIM-listed jam-tomorrow, some day, never investment company Tern (TERN) issued a very odd release this morning through the RNS system via the EQS Corporate News service, an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only/non-regulatory news releases such as marketing messages, corporate and product information into the public domain. We are further told that Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on EQS Corporate News. In other words, it is the equivalent of an RNS Reach – and was not even signed off by Tern’s current Nomad, Allenby.
Tom Winnifrith has already laid out his concerns over the state of play with too many stocks being quite obviously overvalued to a massive extent. One such play I have been following is John Zorbas’ BVI-registered (and therefore not subject to the Takeover Panel’s 30% rule) and AIM-listed URU Metals (URU).
One of the joys of writing for this very fine website is the intelligence of the readership. And that brings me to Pierotlunaire (who I’m sure won’t mind having his tummy tickled!) who asks, in relation to Egyptian gold miner Centamin (CEY) which offered up storming interims on Tuesday: What’s the fundamental basis for your 250p target? Apart from Jefferies at 240p, most brokers come up with less than 200p (although they may update following these results). There’s no point following a tip based on figures plucked from the air, even if the tip is as successful as my tip on Centamin! So it is a very good question.
Of course not! The last reported NAV of AIM-listed jam-tomorrow- next year-never IoT investment company Tern (TERN) was 7.0p, as stated in its FY19 results. This followed a year during which the company raised £3.25 million at a premium to NAV, but still saw a reduction in NAV per share. I guess that is operational gearing at play!
AIM-listed alternative energy supplier Yu Group (YU.) yesterday offered up a half-year trading statement ahead of interims on Wednesday 30 September (deadline day to avoid suspension – a bit of a Red Flag). Having always advertised plenty of cash but turning out to be running short in the net current assets department, is it any different this time? I fear not…..
Controversy is putting it mildly! Yesterday morning at 7.25am AIM-listed Curtis Banks Group plc (CBP) announced the acquisition of Talbot and Muir Ltd , and fintech provider Dunstan Thomas Group Ltd for an initial consideration of up to £21.5 million to be funded through cash and an equity placing. Two minutes later a proposed Placing to raise £25 million was announced. The problem? Well, the company didn’t have the disapplication of pre-emption rights authority to raise £25 million in a placing. But that didn’t stop it.
AIM-listed Prof. Conroy lifestyle outfit Karelian Diamonds (KDR) offered up some good news this morning in that it it has secured vehicular access rights to its Lahtojoki diamond project. Well, it would be, but Karelian hasn’t any cash to spend on exploration so why the shares are up 24% is a mystery.
On Thursday last week AIM-listed Eqtec (EQT) announced a placing and PrimaryBid offering which raised £10 million at 0.45p, a 33.8% discount. That will have hurt existing shareholders, but not as much as the new shareholders who today woke up to learn that the company is in receipt of a filing of legal complaint alleging patent infringement in California from Aries Clean Energy LLC. And the two are unconnected?...
I commented back on June 20th on Zak Mir’s squiggles in the sand when he gave AIM-listed jam-tomorrow investment company Tern (TERN) the kiss of death, suggesting it could make it up to 18p per share. This, of course, was based on his charting analysis and not fundamentals. So how has he done?
On 5th June I flagged up that AIM-listed POS Inspirit Energy (INSP) had again failed to file its Confirmation Statement (the new Annual Return) to Companies House by the due date of 30 March 2020. I repeated the call on June 8th and June 16. Well, here we are on June 28th and there is still no filing! Hello……is there anybody there….?
I suppose that 56% would probably go down as a success in normal times for an open offer from Stobart Group (STOB), but given that it was fully underwritten by placees and at 40p as opposed to the previous closing price of 69.2p, 56% looks pretty poor. Thanks gto the underwriters £100 million was raised but it gets worse….
Technically insolvent AIM-listed POS Trafalgar Property (TRAF) has announced a bailout placing/subscription, courtesy of a Peterhouse special, to raise £750,000 at just 0.08p. Alongside that, there is a corporate loan restructuring which will see £600,000 of intercompany debt morphed into convertible loan notes issued to a director but still leave behind a further £1.4 million debt to said director. Well, you can’t say you were not warned…….
Squiggles-in-the-sand specialist and all round Good German, the Sith Lord Zak Mir, noted yesterday that his bullish comments on POSs on the AIM Casino tend to trigger bear articles on this fine website in his lead-up to comments on AIM-listed Tern plc (TERN). Well I don’t want to disappoint him….after all, as you all know, I’m all heart.
AIM-listed Catenae (CTEA) shares are up this morning in reaction to the latest update on its Covid-bandwagon ramp. This, of course, was a technically insolvent outfit before some clever clogs at Catenae Towers realised that the mug punters would pile into anything to do with Covid-19 and thus a project involving a consortium in which two companies which apparently had been working together for 25 years despite one of them only coming into existence 13 years ago was born. Catenae’s shares roofed it and now two placings later (at a whopping discount) sees Catenae funded perhaps to the end of the year. This morning there was an update on the consortium Covid-19 bandwagon project……
An “Update on IA Grant” announcement from Ethernity Networks (ENET) is actually that it has been informed that its grant application has been declined. The shares have currently responded to 21.5p, approaching 30% lower… but surely for what it states is “a leading supplier of functional acceleration ethernet adapter cards”, this is no major problem?…
Having warned the market on Thursday that a placing was on the way at a substantial discount, the placing duly arrived yesterday morning at two minutes to ten – 37.5 million bits of confetti at 2p to raise £703,000 gross and see off £47,000 worth of liabilities. In some ways one has to congratulate the Broker on a job well done, given that the shares closed Thursday night at 2.65p that amounts to a discount of just 24.5% - a big improvement on the last effort at a monster 77% discount. So where does that leave the company?
AIM-listed POS Catenae Innovation (CTEA) has announced that the holder of a warrant over 15 million shares exercisable at 1.25p has decided to cash in its chips. With the stock currently at 1.6p to sell, you can see why….!
This morning AIM-listed Catenae Innovations (CTEA) revealed the next steps in its Covid-19 spoof: its joint venture to Covid-19 test status app is being rolled out…..to what looks like a single GP practice in Newcastle. That may appear small beer already – not that this stopped the BB loons from piling in first thing this morning – but this roll-out is in fact just a proof-of-concept pilot.
I see that shares in URU Metals (URU), a company run by John Zorbas which Cynical Bear observed seemed to be more interested in mining its shareholders than digging anything of value out of the ground, have dropped to just 80p to sell. This is in the wake of the disgraceful fundraise at a massive 57.5% discount (which was advertised as a 24% discount) to its previous 200p share price. That is bad enough, but there are implications of far worse to come.
In its FY19 report and accounts, Schroder UK Public Private Trust (SUPP) – the former Woodford Patient Capital (WPCT) announced a NAV per share of 49.46p per share. With a hotchpotch of cash-guzzling investments, no income and an almighty overdraft, even before the impact of Covid-19 it was clear there would be casualties to come, and it largest holding was the joke that is Rutherford Health (RUTH) whose valuation is clearly absurd and only supported by Neil Woodford’s policy of overpaying, it was clear to us at ShareProphets that the stated NAV was a total fiction. Now the former Woodford Equity Income Fund (WEIF) has dumped its entire stake.
AIM-listed Yu Group (YU.) has released its AGM statement to be delivered to an empty room at 11.30 today. Of course, the empty room is because of the continuing COVID-19 restrictions, but that is not my gripe. It is the statement, which offers absolutely no insight at all.
AIM-listed jam-tomorrow Internet of Things investment company Tern plc (TERN) finally got around to releasing its FY19 numbers this morning, at 8.15am. To me, the numbers were dire – and the market’s reaction was to mark the stock heavily down: they are off by 25% as I write.
Shares in AIM-listed jam-tomorrow IoT investment company Tern plc (TERN) have been on the rampage again. Having sunk to sub-4p in the wake of its last placing, which had been intended to raise £3 million but only notched up £0.8 million propped up by management support, the stock closed last week at 11.25p, having peaked at 15.75p on Thursday. What gives?
Back on 2 April, AIM-listed jam-next-century gold play (apparently) Conroy Gold and Natural Resources (CGNR) finally got around to fessing up that its much celebrated fundraise six weeks previously has seen a shortfall in that £188,000 of the £302,500 supposedly raised (ie well over half) had not arrived. The whole episode stank of AIM Rules breaches and a letter duly landed on Oxymoron-in-chief Marcus Stuttard’s desk. We were told a further update would follow as soon as possible and in classic Red Flags at Night fashion, yesterday at 4.51pm on a Friday evening – no-one-is-watching o’clock – the update duly arrived. Now if all the money had arrived, I reckon we would have found out at a more normal time like 7am……
One of my first ever tips for ShareProphets was AIM-listed Scancell (SCLP), way back in the 2015 New Year tipfest. It has not covered me in glory, having tipped it when it was hanging around the 23-33p mark as the shares closed last night at around 5p. I had hoped that it would turn itself around and its biotech business would find a willing buyer in the end. But today the shares are up buy a thumping 46% (last seen) on news of Development of vaccine against Covid-19. Should I be celebrating? I’m not so sure….
AIM-listed Internet of Things jam-tomorrow play Tern (TERN) has seen its shares miraculously rise from a low point of just under 4p last month to (last seen) today’s mark of 8.5p. So has Tern offered up a big contract from one of its investees? Er……no! I do know Tern still needs more cash, and that the BBs are full of a progress update from investee Wyld suggesting big things. But of course, there has been no RNS from Tern – something we have seen before ahead of placings which I would argue were on the back of wild speculation which remained uncorrected by Tern. Is it happening again?
That AIM-listed Catenae Innovations (CTEA) is in a state of technical insolvency is surely beyond question. Last night at 5.30pm – no-one-is-watching o’clock – the company announced the appointment of a new sole Broker in the form of Brandon Hill Capital and miraculously, this morning it has announced it has joined a consortium with the objective of building an identity documentation system to record an individual’s Covid-19 test status. Yes folks, this technically insolvent POS is trying to jump on the Coronavirus bandwagon! But this morning’s RNS has to questionable on at least one point…..
“Further to its announcement of 19 March 2020, Escape Hunt (ESC) provides a further update on mitigating actions taken in response to the COVID-19 pandemic”. The shares had fallen below 3p before that March announcement, closed that day at 3.5p and are currently 3.75p...
After last week’s jam-tomorrow ramparoonie, today AIM-listed Haydale (HAYD) offered up a calamitous profit warning. Oh dear, oh dear, oh dear…..
AIM-listed Haydale (HAYD) has announced an initial four-year distributer agreement with Dalian Yibang Technology Co Ltd (DLYB) offering exclusive distributer rights to market Haydale’s electrically conductive graphene-enhanced masterbatch in China and Taiwan. All well and good – and it does indeed appear to be good news – but for all the jam tomorrow, what about cash today?
Since Cynical Bear’s coverage of the Tinkler vs Rest the Board fiasco back in 2018 (when Tinkler and Neil Woodford lost), shares in Stobart Group (STOB) initially trod water and then went into a bit of a tailspin, closing 2019 at a shade over £1 a pop. But then Covid-19 struck: bearing in mind one of its two prime assets is an airport, it has been bad news ever since and the shares are currently just 50p. So what of today’s announcement?
AIM-listed Yu Group (YU.) has delivered its FY19 results – this despite claiming it would defer them in line with the FCA’s moratorium (which did not apply to AIM companies)! CEO Bobby Kalar was pleased with the positive results so far as the company recovers from an accounting scandal but I’m not so sure that shareholders should be.
AIM-listed jam-tomorrow IoT investment company Tern (TERN) has offered the market a Covid-19 update. Emphasising its recent £0.8 million fundraise several times (but not mentioning it was trying to get £3 million and failed magnificently) Tern wants us to think the portfolio is well prepared…..let’s see what the ShareProphets RNS Translation Service thinks!
AIM-listed Yu Group (YU.) has offered up a Covid-19 statement and delayed its results, mindful of the recent request from the Financial Conduct Authority. Except that the FCA’s request as per its RNS released ended with This statement does not apply to AIM companies. Do I smell a rat? You bet!
AIM-listed Neil Woodford dog Eve Sleep (EVE) released FY19 results this morning. My immediate thought is who would buy a bed right now, amid fears of Coronavirus, job losses and with the UK in near total lockdown? But these are last year’s numbers, before the invisible invader was around and it looks to me as though Eve will need even more cash, despite its laudy claims that the latest rebuild strategy has left the company operationally profitable. Let’s take a look at what that actually means……
AIM-listed Trafalgar Property (TRAF) has made a total shambles of being a housebuilder in a housing boom. It listed on AIM in 2013 and at the last count was sporting just £14,000 of cash as at 18 December and recorded shareholder funds of MINUS £2.9 million at the end of September in its interims released at 4.23pm on the Friday before Christmas. Now it wants to utilise its property development skills to move into hydroponics – growing vegetables in test-tubes! Oh....
Fully-listed Shetty vehicle and owner of Travelex which is surely in trouble from the panic of corona virus Finablr (FIN) has updated on the good Dr Shetty’s shares. But the update leaves far too many questions unanswered and the shares remain a stonking sell.
With markets in turmoil over the corona virus, it is a terrible time to be rattling the tin for cash-guzzling AIM stocks. And that brings me to jam-tomorrow Iot investment company Tern (TERN): how much cash has it got left and when's the placing?
Having first landed on fully-listed Finablr at the back end of January when I asked if it was a house of cards at 95p, I have been supping at the ouzo ever since – and the shares are down again today to just 46.75p last seen. But the stock remains a slam-dunk sell – especially in the light of what has happened at fellow Shetty-inspired vehicle NMC Health (NMC). And then there is the cyber-attack at its Travelex operation….and coronavirus…..and the continued silence from the company.
Yes folks, it is time for an update on my five slam-dunk sells for 2020 – and the writing is on the wall as the anti-portfolio slides. At the end of January the score was an overall drop of 9.8% on a bid to bid basis. One month on the slippage has accelerated amongst my five picks from the AIM Casino, namely Tern (TERN), URU Metals (URU), AIM-China Filthy Forty play Walcom (WALG), Catenae Innovation (CTEA) and Yu Group (YU.)
I covered technically insolvent Conroy Gold and Natural Resources’ (CGNR) interims and came to the obvious conclusion that it was technically insolvent. Yesterday its sister company (with largely the same management), AIM-listed Karelian Diamonds (KDR) followed with its own half-year numbers and guess what. But the statements are just unutterable tripe which, I suggest, are intended to mislead.
Having made a total shambles of its half-year trading statement to the end of December, contradicting itself the very next day, AIM-listed Haydale (HAYD) has offered up dire interim results. The company will need more cash – and given the fiasco last time, that spells bad news for shareholders.
Of course there is insolvency as far as the law is concerned, and insolvent in that there isn’t enough cash to pay the bills but AIM-listed Conroy Gold and Natural Resources (CGNR) had not the cash to pay its bills, but still goes on. The interims to last November 30 show that it clocked up a pre-tax loss of EUR 278,000 and had negative net current assets of a stonking MINUS EUR 3.7 million!
You cannot say you were not repeatedly warned here on ShareProphets – we have been bears from the start of Aston Martin’s latest incarnation as a listed vehicle (geddit?) and this morning we learn that having listed at a stonking £18 per share in October 2018, there is a rights issue on offer at just 207p. Oh, and the full year results are out….
Withshares in NMC health (NMC) – a soon-to-be-retired member of the illustrious FTSE100 – now suspended in the wake of a string of revelations over founder and now ex-co-chairman’s share dealing shenanigans, dodgy related party share guarantees which one assumes will haunt the company’s bank balance in due course and apparent discrepancies at the bank, Muddy Waters must be celebrating a seemingly total win. But what of fellow main-market play Finablr (FIN), where the warning signs are surely flashing red for similar revelations regarding the same people but as yet the company is remaining tight-lipped. That surely is a giant-sized Red Flag…
At eleven minutes past ten this morning AIM-listed penny-dreadful, to quote poor Malcolm Stacey, Tertiary Minerals (TYM) announced a placing of one hundred million bits of confetti at 0.275p to raise just £275,000 (before expenses) and a shiny new Broker in the form of Peterhouse, which arranged the issue and is set to receive five million warrants at the placing price. Nice work for the flippers – especially since the shares were 0.41p immediately before the announcement and thus the discount was a tasty 33%. And compared to the 0.87p the stock hit in the wake of the ramptastic announcement the day before (awful, as usual) results were released the placees must think it is Christmas.
I suspect that ShareProphets readers already know the answer: that the news is really not all that great and thus it looks like a ramparoonie of the first order! Surely it could not be placing ahoy, could it?
I had been wondering what was going on at AIM-listed Conroy Gold and Natural Resources (CGNR). At the turn of the year the shares were languishing at just over 5p and raced ahead to around 15p until last Wednesday when the shares staring slipping. Of course there is no insider dealing – this is AIM after all – and surprise surprise this morning we learn of a placing and subscription to raise a poxy amount of cash to feed the electricity meter.
Of course it is! Muddy Waters may be laughing all the way to the bank with reference to NMC Health (NMC), but it must be kicking itself in San Francisco for having missed out on fellow good Dr Shetty outfit Finablr (FIN). The last we heard from Finablr was a week ago when the company announced that, like NMC – which has now ‘fessed up at least in part – The Company has very recently been made aware of purported arrangements between Dr BR Shetty, His Excellency Saeed Mohamed Butti Mohamed Al Qebaisi and Khaleefa Butti Omair Yousif Al Muhairi which may be relevant to their respective interests in the Company's shares. With at least 56% of the company’s shares pledged and perhaps more if similar undisclosed arrangements to the ones at NMC have been made, there is surely an urgency for the board of Finablr to get to the bottom of this.
Further to my article last weekend which pointed out that someone at former David Sefton outfit Iconic Labs (ICON) couldn’t add up with reference to its RNS of 4.08pm on Friday 7 February (no-one-is-watching o’clock) announcing a capital reorganisation, a week later the company finally got around to correcting it…….at no-one-is-watching o’clock (4.09pm) yesterday. Perhaps yesterday’s crony capitalist lunch at shareholders’ expense was alcohol-free.
NMC Health (NMC) has announced highly preliminary approaches from Kohlberg Kravis Roberts (KKR) and GK Investment Holding (GKI) regarding possible offers for the company. But in tandem, a second RNS from NMC suggests that Dr Shetty’s holdings and others’ may not be all they appeared to be. This was accompanied by an RNS from Finablr (FIN) suggesting similar shenanigans may be on the cards regarding the same people. Both companies are trying to get to the bottom of it, but from my perspective it all stinks and I would not be hanging around to find out what the true position actually is with either.
Tom Winnifrith has already taken his sup from the ouzo bottle with regard to seeing David Sefton “resigned” from Iconic Labs (ICON) and called it insolvent. In a statement at 4.08pm on Friday – no-one-is-watching o’clock – which was littered with Red Flags, we were told that the company’s business is now generating revenues and starting to achieve real growth but it plans a capital restructuring and has agreed a new death spiral as it is not currently possible to raise conventional capital. So that’s alright then! And courtesy of ShareProphets Nomad Services I forecast a correction first thing tomorrow for it seems someone did rather too well at lunchtime on Friday.
Following my letter to AIM Regulation this morning, AIM-listed Haydale Graphene (HAYD) has attempted to quell the reaction to yesterday’s trading update, which appears to show that the company was allowed by its Nomad to breach AIM Rules by offering a clarification. But it is attempting to clarify the unclarifiable.
One day short of four months on from its first announcement, AIM-listed Vast Resources (VAST) has at long last confirmed receipt of the first tranche of the death spiral funding it said it would not do. So yesterday’s announcement that the cheque really was in the post this time appears to have been true. Quite why it has taken so long remains a mystery, but whatever: let the death spiral commence. But how much actual cash does Vast gain from this charade?
AIM-listed Haydale Graphene Industries (HAYD) offered up a pretty grim trading statement this morning showing that sales at its US unit were materially below those of H1 2019 during H1 2020. Oopsie. Meanwhile UK operations suffered from longer than anticipated lead times and sales fell short of directors’ expectations. Double oopsie. And the company has shuttered its Taiwan operation which will lead to a revenue shortfall in H2 of around £0.4 million. Triple oopsie – and now we are told that full year sales will come in below market expectations (whatever they are). What’s not to like?!
AIM-listed energy supplier with recent accounting issues Yu Group (YU.) has released a full year trading statement. Like its half year trading statement last year, it is again full of holes: it tells us about the cash, but what about payables? And whilst losses appear to have been reduced, references to adjusted EBITDA don’t fool me: the company is still leaking cash.
AIM-listed Vast Resources (VAST), a company about which I have been a perennial bear and issued a sell call in the run-up to Christmas when the debt funding didn’t appear, has released interims to 31 October this afternoon. At 3pm on a Friday! What horrors do we find?
Having announced plans to depart the AIM Casino on Thursday, Cloudbuy (CBUY) slipped out a Director Dealing RNS at no-one-is-watching o’clock last night at 5.47pm showing that departing Chairman Ronald Duncan and his departing CEO wife Lyn Duncan have been dumping shares as fast as they can. If ever there was a signal to follow…….
My slam-dunk sells for 2019 came home ahead, but only 8% down on their starting prices. Of the five, Haydale (HAYD) was an early success as the rescue bailout I had long predicted it needed finally arrived…..and smashed the shares from 31.5p at the start of the year to a couple of pence.
Peter Brailey has already offered his list of sells for 2020 in the form of his Vomit List of useless oilers, so here is my 2020 list of Slam-Dunk sells. I doubt there will be much borrow available on any of them so shorting may not be possible (although two might offer up some) but the main message is stay away!
Last week AIM-listed Inspirit Energy (INSP) released results at no-one-is-watching o'clock, on Christmas Eve Eve. It seems the trick of avoiding ShareProphets scrutiny by releasing bad results the day before good days to bury bad news is spreading, for yesterday – New Year’s Eve Eve - at 4.23pm came interims from AIM-listed URU Metals (URU). Except ShareProphets was watching, always keen to highlight news that companies don’t want you to see. And oh dear, oh dear…..
Following last week’s admission that despite deals signed with Bradford City FC and Southend United Community and Educational Trust last Thursday but by Friday (after-hours) a profit warning had to be issued, AIM-listed Catenae Innovations (CTEA) has announced that the proposals put to a GM yesterday were passed…….and its sole NED (apart from the Interim Chairman) has resigned with immediate effect. Oh, and its financial position continues to be dire. The shares are off by 23% since my last warning over the weekend, but it seems there is more to come.
If you know your results are so poor they will be an immediate sell signal to even the most diehard of investors, the best time to release them is at no-one-is-watching o’clock. In theory, peak no-one-is-watching o’clock lies on Christmas Eve, especially after-hours, but with our annual watch on such matters perhaps Christmas Eve is not quite the best time to tell investors what a total POS your company is. And so AIM-listed Inspirit Energy (INSP) released its full year numbers to June 2019 at 2.35pm yesterday: truly the behaviour of pedants. But ShareProphets, always eager to share what companies do not want you to know, was indeed watching and the numbers were truly dire.
Catenae Innovation (CTEA) snuck out another profit warning on Friday at 5.02pm – truly no-one-is-watching o’clock, telling the market that its trading performance continues to be below management expectations as notified on 11 September and its financial position remains weak. Oh dear, of dear – things aren’t getting any better for the former Milestone Group (MSG) showing once again that Warren Buffett’s adage that when a bad company meets good (or only slightly better) management, it is the reputation for the former which prevails.
AIM-listed Vast Resources (VAST) has, to say the least, a chequered history when it comes to raising convertible funding, with a string of highly dilutive deals in the past which often were then binned and in the past it told shareholders it would not do any more. But it did. Or, rather, it announced a deal on 24 October but almost two months on, no cash has appeared. Except that the deal was first announced on 1st October.
AIM-listed Yu Group (YU.) released an update this morning detailing in part a new hedging facility with SmartestEnergy Limited. On the face of it, it is good news but I rather suspect that when the dust settles it will be seen as not so good. As ever, on AIM, it is not what is said that matters: it is what is unsaid.
Perma-dog Aston Martin Lagonda (AML) has been a predictable disaster for investors since its latest iteration joined the stockmarket last year and ShareProphets readers were well warned off by Gary Newman ahead of the IPO and Chris Bailey was no less scathing HERE. Indeed, Tom Winnifrith wondered HERE whether it would go bust for the seventh time. On Friday evening after hours, at 5.05pm – no-one-is-watching o’clock on General Election results day - the company issued a statement. Uh-oh…….
Friday lunchtime is hardly a time to issue news for people to notice and doing it on election results day suggests that there is bad news being buried. And so Woodford Patient Capital (WPCT) announced it was changing its name to Schroder UK Public Private Trust (SUPP) as of Monday to reflect the appointment of Schroders at manager, replacing the disgraced Neil Woodford who is off to count his piles of cash from running the Woodford funds into the ground. The company also announced an extended banking facility – and it is here that the bad news lies.
Not content with leaving burying bad news on polling day to the likes of Purplebricks (PURP) or Versarien (VRS), this morning – election results day – AIM-listed Anglesey Mining (AYM) joined the fray with its Interims to September. They are truly horrid.
I stress that as far as I know Adam Reynolds has nothing whatsoever to do with AIM-listed jam-tomorrow IoT Investment Company Tern (TERN) but it seems that Tern has borrowed his keyboard to offer up this morning’s portfolio update – where there are no meaningful numbers. More to the point, there is still no comment on the apparent $10 million fundraise by its principal investee, Device Authority (DA), which suggests to me that the whole story was utter poppycock and the market should have told so. But instead, Tern got a placing away – for the second time in its history. However, the few numbers offered are truly alarming.
I still reckon AIM-listed graphene outfit Haydale (HAYD) needs to get a placing away pronto but today comes the bombshell that the CFO – who has only been in the job for 10 months – is stepping down. Do I detect a case of rats and sinking ships?
Amazing. Yesterday, having promised news on a $13.5 million finance facility at regular intervals since 1 October, AIM-listed VAST Resources (VAST) essentially told us it didn’t know when it would come through. This morning and bingo, its arrived. Its nice to feel the board is fully in control of things. But having told us in December last year that it would not do any more death spirals, guess what! And worse still, the previous clientele of this fine upstanding finance firm appears to consist of the fraud MySquar (MYSQ), and Bushveld Minerals (BMN) back in the days when it was a penny stock dreadful gasping for cash.
AIM-listed Woodford dog and wannabee computer-generated drugs developer Verseon (VERS) has announced the sale and leaseback of its headquarters in Fremont, California. It says the sale will provide working capital but in case the $34.7 million price tag looks like good news, it is most certainly not. This is a calamity and by my calculations Verseon could be technically insolvent even upon completion.
AIM-listed Vast Resources (VAST) has responded to my jibes this morning over the non-appearance of Mr Godot three times (beating Samuel Beckett) in that its finance facility has still not been signed and the Chiadzwa diamond project has still not been signed off. We are told:
It is surely now only a matter of time before this AIM-listed Woodford Dog is taken out and shot as an act of mercy. Out of cash, piled up with bills to pay, with no income, a failed ruse to play the crypto-currency game and with benefactor Neil Woodford now out of play, AIM-listed revolutionary drugs-from-a-computer generating machine Verseon (VERS) has announced it is looking to sell its HQ, the research, development and operations facility in Fremont, California. There is a slight snag, however, in that it is already mortgaged. What will the forced seller get for it?
My most recent call to sell fashionable graphene promote Haydale (HAYD) was on its full-year trading update back in July, an update which told readers very little: I said sell at 1.775p and the shares are now just 1.125p. More ouzo for me!
Previously writing on Time Out Group (TMO), last month I noted balance sheet deterioration after interims showing net revenue only 10% higher than in the corresponding 2018 period to £24.7 million, a little changed attributable loss of £11.4 million and £16.6 million of net investing spending more than depreciation + amortisation and concluded, with the shares at around 128p, I still think Woodford - albeit eventually, for the wrong reason and at a lower price! - was correct to sell. Now “Proposed Placing”…
My slam-dunk sells for 2019 are looking better and better (if you are a bear). In my last piece (in September) the average had got almost back to flat but the interim results season took its toll on one of the portfolio and I am now in profit.
At Woodford Patient Capital (WPCT) we learn this morning of a triple valuation write-down which will cost 3.1p per share in terms of NAV. Cynical Bear wonders if two of them are Precision Biopsy (which has actually stopped operations) and SciFluor which Allied Minds (ALM) – in which Woodford has also invested – has stopped funding. The other may be Sphere Medical which went into administration. We are told: